|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Income | |||||
| Net Loss | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Fair value adjustment for marketable securities | |||||
| Restricted common stock issued for services | |||||
| Bad Debt Expense | |||||
| Change in operating assets and liabilities: | |||||
| Royalties receivables | |||||
| Prepaid expenses | |||||
| Deferred tax asset, net of valuation allowance | |||||
| Accounts payable and accrued liabilities | |||||
| Accounts payable and accrued liabilities – related parties | |||||
| Net cash flows used in operating activities | |||||
| Net cash flows provided by investing activities | |||||
| Proceeds from note payable – related party | |||||
| Purchase and cancellation of stock | |||||
| Net cash flows provided by (used in) financing activities | |||||
| Foreign exchange effect on cash | |||||
| Net decrease in cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
| Supplemental disclosure of cash paid for: | |||||
| Interest | |||||
| Income taxes | |||||
| Issuance of restricted stock for prepaid director fees | |||||
Loading...